908 Devices Inc Asset Resilience Ratio
908 Devices Inc asset resilience ratio. 908 Devices Inc (MASS) has an Asset Resilience Ratio of 23.66% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 908 Devices Inc liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of 908 Devices Inc (2022–2025)
Asset resilience ratio of 908 Devices Inc from 2022 to 2025. This chart shows how 908 Devices Inc's Asset Resilience Ratio has changed over time. Read 908 Devices Inc debt and liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down 908 Devices Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see how large is 908 Devices Inc's balance sheet.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $44.18 Million | 23.66% |
| Total Liquid Assets | $44.18 Million | 23.66% |
Asset Resilience Insights
- Good Liquidity Position: 908 Devices Inc maintains a healthy 23.66% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
908 Devices Inc Industry Peers by Asset Resilience Ratio
Compare 908 Devices Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
HOB Biotech Group Corp Ltd
SHG:688656 |
Medical Devices | 2.62% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
Applied BioCode
TW:6598 |
Medical Devices | 9.75% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
|
Cleo Diagnostics Ltd
AU:COV |
Medical Devices | 94.64% |
|
Radiant Innovation
TWO:3373 |
Medical Devices | 0.82% |
|
Impedimed Ltd
AU:IPD |
Medical Devices | 46.15% |
|
Memphasys Ltd
AU:MEM |
Medical Devices | 0.00% |
908 Devices Inc Asset Resilience Ratio by Year (2022–2025)
908 Devices Inc asset resilience ratio by year from 2022 to 2025. The table below shows the annual Asset Resilience Ratio data for 908 Devices Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 22.34% | $42.45 Million | $190.07 Million | +6.30pp |
| 2024-12-31 | 16.03% | $25.57 Million | $159.48 Million | +3.89pp |
| 2023-12-31 | 12.14% | $24.64 Million | $202.98 Million | -- |
| 2022-12-31 | 0.00% | $0.00 | $242.59 Million | -- |
About 908 Devices Inc
908 Devices Inc. provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; XplorIR, a handheld device that uses FTIR spe… Read more